jimells
Senior Member
- Messages
- 2,009
- Location
- northern Maine
This is interesting about Dr Bansal. Just last night I was reading about him in this statement by Professor Edwards regarding the Invest In ME Rituximab trial:
I have very high confidence in Professor Edwards' opinions (I know, appeal to authority) so this thread is creating a bad case of cognitive dissonance for me.
(it sure is hard to tell the players without a score card)
Jonathan Edwards said:A recent study by Dr Amolak Bansal and colleagues also suggests that B cells may be functioning abnormally in a significant proportion of people with ME/CFS. ...
The UCL service set up when we started treating rheumatoid arthritis, lupus and a range of other conditions has the most extensive experience. ...
UCL also has a new Clinical Trials Research Facility with staff appointed to manage trials of this sort.
Importantly, there is enthusiasm amongst local teams for a rituximab ME/CFS trial.
I have suggested to IiME that this would be the ideal centre for such a trial, to be set up in collaboration with clinicians with expertise in ME/CFS from around London, and in particular Dr Bansal.
IiME have accepted this and this is the planned and preferred research base for this trial.
I have very high confidence in Professor Edwards' opinions (I know, appeal to authority) so this thread is creating a bad case of cognitive dissonance for me.
(it sure is hard to tell the players without a score card)